Overall, our findings suggest that RET G4 stabilization by small molecules may represent a suitable tool to control oncogene transcription for therapeutic purposes in RET-dependent MTC, and furnish the biological rationale for the development of novel G4 stabilizing-based treatment approaches that could be extended to other oncogene-driven neoplastic diseases. Here, RET is linked to neoplasm.